Adial Pharmaceuticals, Inc · NASDAQ:ADIL

Claiborne Cary J received 37,985 Adial Pharmaceuticals, Inc shares as an award (Form 4)

Traded Apr 7, 2026 · Filed Apr 9, 2026

On Apr 7, 2026, Claiborne Cary J (Director, Chief Executive Officer) received 37,985 Adial Pharmaceuticals, Inc shares as an award, leaving 40,417 shares. Filed Apr 9, 2026 (Form 4).

Awarded
37,985 shares
Holding after
40,417 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 7, 2026Common StockAward37,98540,417Direct

Source

View original at SEC

Related